Episode summary
US Launches New Strikes on Iran as Hormuz Traffic Slumps | Bloomberg Businessweek
Bloomberg Businessweek Daily
· · 44 min · Hosts: Carol Massar, Tim Stenovec · Guests: Nick Wadhams, Ed Ludlow, Madison Muller, David George
Summary
The episode centered on three market-moving stories: the US-Iran conflict, the surge in semiconductor spending tied to AI demand, and Eli Lilly’s $3.8 billion move into psychedelic medicine. On the Middle East, the host and a guest discussed how fresh US strikes, disrupted traffic through the Strait of Hormuz, and Iranian retaliation are raising security and economic risks while leaving the administration with few clear off-ramps. The guest argued that the conflict could keep cycling between ceasefire and renewed attacks, with consequences for oil, shipping, and US troops.
The tech segment focused on TSMC’s strong results and raised outlook, but also on the market’s growing skepticism about how much more AI infrastructure spending can run before returns show up. Ed Ludlow said the buildout is now a multi-year chain reaction from chipmakers to hyperscalers to data centers, and that investors are increasingly bullish on spending but still lack proof on end-demand payoff.
In healthcare, Madison Muller said Lilly’s purchase of Atai Life Sciences signals that psychedelics are moving from fringe to legitimate medicine, especially for treatment-resistant depression. A later banking segment argued that US banks are benefiting from an unusually strong mix of record fees, net interest income, and low credit costs, though a senior analyst warned the sector may be nearing a peak in returns.
Key takeaways
- The guest said the US-Iran conflict makes regional US service members less secure and could hit oil and household pocketbooks if strikes expand further.
- The guest said shipping through the Strait of Hormuz can be choked off with relatively few resources, making the market impact hard for Washington to control.
- Ed Ludlow said TSMC’s guidance reinforces a multi-year AI capex boom, but investors still lack proof that software and revenue growth will match the hardware spend.
- Madison Muller said Lilly’s $3.8 billion Atai deal shows large drugmakers now see psychedelics as a legitimate treatment area, not a fringe bet.
- David George said bank earnings are unusually strong because fees, net interest income, and credit quality are all favorable at once, but that may mark a peak in returns.
Notable quotes
“The war between the US and Iran continuing. The US intensifying strikes against Iran overnight hitting an oil tanker near the country's main export terminal”
“what they said was not just this year, but boost CapEx multiple times over multiple years”
“this is an area of medicine that is legitimate, that people are interested in, that we're really seeing evidence and and promising results in clinical trials”
“the story right now unequivocally has to be capital markets. I've been doing this a long time”
How the episode opens
Bloomberg Audio Studios. Podcasts, radio, news. This is Bloomberg Businessweek Daily, reporting from the magazine that helps global leaders stay ahead with insight on the people, companies, and trends shaping today's complex economy. Plus, global business, finance, and tech news as it happens. The Bloomberg Businessweek Daily podcast with Carol Masser and Tim Stenovec on Bloomberg Radio.
Uh we also continue to keep an eye on what's going on in the Middle East. The war between the US and Iran continuing. The US intensifying strikes against Iran overnight hitting an oil tanker near the country's main export terminal.
A shipping traffic slumped through the critical Strait of Hormuz. Iran responded by firing at American bases in Kuwait and Jordan and Tehran seems in no mood to back down in the face of President Trump's warning that he will escalate strikes.
We head to the Bloomberg News Washington D.C. Bureau and to our national security reporter Nick Wadhams who joins us from there. Nick, as we as a nation, the question I think a lot of people have, um I don't know Carol was was asking this question earlier, are we less secure, are we more secure the longer this war between the US and Iran goes on?
Uh
Uh are we less secure? I You know, I think the big question that you have to look at this from a few angles. One is obviously US bases in the region and US allies.
So, they're willing this to sort of partner with the United States in the long term. Uh big question there. They are obviously getting a lot more anxious given that Iran's way of responding has been to attack US allies as well as US bases.
So, service members in the region certainly less secure.
From the episode’s captions: roughly the first two minutes, lightly cleaned. Keep watching on YouTube →
Topics
- iran attacks
- strait of hormuz shipping
- ai trade worries
- healthcare deals
- fda drug approvals
Companies and tickers mentioned
- TSM
- LLY
- MRK
- TSMC
- Eli Lilly and Company
- Merck & Co.
- Baird
Watch the episode
Watch “US Launches New Strikes on Iran as Hormuz Traffic Slumps | Bloomberg Businessweek” on YouTube
Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.
More from Bloomberg Businessweek Daily
-
Bloomberg Businessweek Weekend - November 13th, 2026 | Bloomberg Businessweek -
Inside Jensen Huang’s Final Hours as Nvidia CEO | Bloomberg Businessweek -
Jensen Huang's Exit Kicks Off Nvidia Strategy Reset | Bloomberg Businessweek -
Special Episode: Bobby Jain on Why He Chose Millennium Again | Bloomberg Businessweek -
Bloomberg Businessweek Daily Podcast: Jensen’s Nvidia Departure -
Take-Two Releasing Long-Awaited Grand Theft Auto VI Next Week | Bloomberg Businessweek
Bloomberg Businessweek Daily, this episode and its artwork belong to Bloomberg. Octagon is not affiliated with the show; this page is an independent summary.
